Autologous stem cell-based therapy offers many advantages over other nonsurgical treatments of peripheral arterial disease. Transplant stem cells are a renewable source of multiple cytokines and growth factors. Autologous adult stem cells are not rejected and do not form teratomas. Early preliminary results indicate that adult stem cell therapy is safe and effective in patients with critical limb ischemia.
Kannel WBThe demographics of claudication and aging of theAmerican population. Vasc Med. 1996;1:60-64.
2.
Coni N., Tennison B., Troup M.Prevalence of lower extremity arterial disease among elderly people in the community. Br J Geri Pract. 1992;42:149-152.
3.
Bowlin SJ, McDalie JH, Flocke SA, et al. Epidemiology of intermittent claudication in middle-aged men . Am J Epidemiol. 1994;140:418-430.
4.
Kannel WB, McGee DLUpdate on some epidemiologic features of intermittent claudication: the Framingham Study. J Am Geriatr Soc. 1985;33:13-18.
5.
Criqui MH, Langer RD, Fronek H., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Eng J Med. 1992;326:381-386.
6.
The Vascular Surgical Society of Great Britain and Ireland.Critical limb ischaemia: management and outcome report of a national survey. Eur J Vasc Endovasc Surg. 1995;10:108-113.
7.
Tateishi-Yuyama E., Matsubara H., Murohara T., et al; Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators.Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002;360:427-435.
8.
Huang PP, Li SZ, Han MZ, et al. Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities. Thromb Haemost. 2004;91:606-609.
9.
Burt R., Pearce W., Luo K., et al. Hematopoietic stem cell transplantation for cardiac and peripheral vascular disease. Bone Marrow Transplant. 2003;32(suppl 1):S29-S31.
